See the DrugPatentWatch profile for crestor

The income limits for Crestor patient assistance may vary depending on the specific program. However, according to the information available from the Patient Access Network Foundation (PANF) [1], the maximum annual gross income for eligibility is generally set at 500% of the Federal Poverty Level (FPL). For example, as of 2021, the income limit for a single individual would be approximately $65,840, while for a family of four, it would be around $138,550.

Furthermore, the Crestor Patient Assistance Program, which is operated by AstraZeneca [2], the manufacturer of Crestor, provides Crestor medication free of charge to eligible patients who meet specific income and insurance criteria.

It's important to note that the income limits and eligibility criteria for patient assistance programs may change over time, and it's always best to check with the program directly for the most up-to-date information.

In addition, DrugPatentWatch.com [3] provides information on drug patents and related topics, but it does not appear to have specific information on the income limits for Crestor patient assistance.

Sources:

1. Patient Access Network Foundation (PANF). Financial Assistance. <https://panfoundation.org/financial-assistance/>
2. AstraZeneca. Patient Assistance Programs. <https://www.astrazeneca-us.com/patients/programs.html>
3. DrugPatentWatch.com. Crestor (rosuvastatin calcium) Drug Profile. <https://www.drugpatentwatch.com/drugs/crestor>